Ris Orangis, France

Julien Lafosse




Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Julien Lafosse: Innovator in Ophthalmic Emulsion Technology

Introduction

Julien Lafosse, a skilled inventor based in Ris-Orangis, France, has made significant contributions to the field of ophthalmic technology. His innovative work is exemplified in his patent related to the manufacturing of oil-in-water emulsions, which are vital for various ophthalmic applications.

Latest Patents

Lafosse holds a patent for a "Process for manufacturing ophthalmic oil-in-water emulsions." This invention describes new processes that enhance the preparation of oil-in-water emulsions specifically designed for use in ophthalmic applications. The methodology includes creating a pre-concentrate of the emulsion and subsequently diluting it to achieve the desired formulation. Additionally, the invention encompasses pharmaceutical compositions formulated with such emulsions, offering new methods to treat eye diseases or conditions effectively.

Career Highlights

Currently, Julien Lafosse is associated with Santen Sas, a company that specializes in the development of innovative pharmaceutical products for eye care. His role allows him to apply his expertise in formulating ophthalmic solutions that contribute to the health and well-being of patients suffering from eye-related conditions.

Collaborations

Throughout his career, Lafosse has collaborated with talented professionals, including Gregory Lambert and Frederic Lallemand. These partnerships not only foster creativity but also enhance the development of innovative solutions in the pharmaceutical industry.

Conclusion

Julien Lafosse's dedication to advancing ophthalmic technology through his inventive processes demonstrates his commitment to improving patient care. With his patent reflecting his expertise and collaboration with other professionals, he continues to pave the way for innovative treatments in the field of eye healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…